We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About KisoJi Biotechnology Stock

Invest in or calculate the value of your shares in KisoJi Biotechnology or other pre-IPO companies through EquityZen's platform.

Get Started

KisoJi Biotechnology Stock (KISB)

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

About KisoJi Biotechnology Stock

Founded

2009

Industries

Software, Artificial Intelligence, Data and Analytics

KisoJi Biotechnology is an early-stage biotechnology company developing antibodies for the treatment of various cancers. Unlike traditional industry methods, the full spectrum of antibody diversity can be identified and visualized, allowing for the pinpointing of clusters with desired characteristics and the optimization of lead candidate selection. The antibody platform includes multi-species single-domain antibody transgenic mice, AI-driven antibody fingerprinting to find the best fit with specific epitopes on any target, and a toolkit for creating robust, easily manufacturable multi-specific antibodies.

KisoJi Biotechnology Press Mentions

Stay in the know about the latest news on KisoJi Biotechnology

KisoJi Biotechnology Management

Leadership team at KisoJi Biotechnology

Chief Financial Officer

Michael Dixon

Co-Founder, Chief Executive Officer

David Young

Locked Features

Join now and verify your accreditation status to gain access to:

  • KisoJi Biotechnology Current Valuation
  • KisoJi Biotechnology Stock Price
  • KisoJi Biotechnology Management
  • Available deals in KisoJi Biotechnology and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • KisoJi Biotechnology Cap Table and Funding History by Share Class and Liquidity Preferences
    • KisoJi Biotechnology Revenue and Financials
    • KisoJi Biotechnology Highlights
    • KisoJi Biotechnology Business Model
    • KisoJi Biotechnology Risk Factors
  • KisoJi Biotechnology Research Report from SACRA Research
Join Now

Trading KisoJi Biotechnology Stock

How to invest in KisoJi Biotechnology stock?

Accredited investors can buy pre-IPO stock in companies like KisoJi Biotechnology through EquityZen funds. These investments are made available by existing KisoJi Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell KisoJi Biotechnology stock?

Shareholders can sell their KisoJi Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."